Cardiovascular journalCurrentCardio coverage
JACC: CardioOncology
What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.
Follow all of it, or only:You follow this. See your week →Explore JACC CardioOncol with filters →
- Recent
- 3 Briefs
- past 90 days
- Archive
- 112 Briefs
- research published Apr 2023 – Sep 2026 · 20 undated
- Editorial
- –
- no Weekly issue published yet
- Impact Factor
- 15.5
- 2025 · Journal Citation Reports
Topics
- Coronary & ACS32.7%
- Heart failure1210.7%
- Arrhythmias & EP32.7%
- Hypertension10.9%
- Prevention & lipids21.8%
- Cardiometabolic & kidney21.8%
- Pulmonary vascular & VTE43.6%
- Cardio-oncology & other7567.0%
Evidence types
- Randomised controlled trials76.3%
- Secondary analyses65.4%
- Meta-analyses98.0%
- Cohort studies6961.6%
- Case-control studies32.7%
- Cross-sectional studies54.5%
- Diagnostic & prognostic43.6%
- Mechanistic studies10.9%
- Guidelines & statements21.8%
- Other research65.4%
Shares are of the 112 Briefs CurrentCardio has covered from JACC CardioOncol, by primary topic and study type; a Brief without a primary topic is in no topic row.
Publication activity
- 20265 Briefs
- 202524 Briefs
- 202432 Briefs
- 202331 Briefs
Latest from JACC: CardioOncology
JACC CardioOncol
Real-World Cardiotoxicity of Biosimilar versus Reference Trastuzumab in Early HER2-Positive Breast Cancer
Cohort studyCardio-oncology & other
JACC CardioOncol
Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral
Secondary analysisCardio-oncology & other
JACC CardioOncol
Inflammatory Cell Profiles in Early- and Late-Manifestation Immune Checkpoint Inhibitor Myocarditis
Cohort studyCardio-oncology & other
JACC CardioOncol
Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk
Cohort studyCardiometabolic & kidney
JACC CardioOncol
Cardiovascular Adverse Events Associated With Bispecific T-Cell Engager Therapy
Cohort studyCardio-oncology & other
JACC CardioOncol
Pretreatment Circulating Vascular Biomarkers Predict Cancer Therapy–Related Cardiac Dysfunction During HER2+ Breast Cancer Treatment
Cohort studyCardio-oncology & other
JACC CardioOncol
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors
Randomised controlled trialCardio-oncology & other
JACC CardioOncol
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma
Cohort studyCardio-oncology & other
JACC CardioOncol
Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis
Diagnostic or prognostic studyHeart failure
JACC CardioOncol
Risk of Heart Failure Hospitalization in Patients Treated With Osimertinib
Cohort studyCardio-oncology & other
JACC CardioOncol
Anthracycline Dose, Myocardial Injury, and Change in Left Ventricular Function in the Cardiac CARE Trial
Secondary analysisCardio-oncology & other
JACC CardioOncol
Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy
Cohort studyCardio-oncology & other
JACC CardioOncol
Cardiovascular Risk, Health Metrics, and Cancer Prediction
Meta-analysisPrevention & lipids
JACC CardioOncol
Epigenetic Age Acceleration Mediates Treatment Effects on Cardiometabolic and Cardiovascular Risk in Childhood Cancer Survivors
Cohort studyCardio-oncology & other
JACC CardioOncol
Risk of Hematologic Malignancies in Patients With Acute Myocardial Infarction
Cohort studyCoronary & ACS
JACC CardioOncol
Blood Pressure Lowering and Risk of Cancer
Meta-analysisHypertension
JACC CardioOncol
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal Cancer
Cohort studyCardio-oncology & other
JACC CardioOncol
Immune Checkpoint Inhibitor–Related Myocarditis With or Without Concomitant Myopathy
Cohort studyCardio-oncology & other
JACC CardioOncol
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis
Cohort studyHeart failure
JACC CardioOncol
Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer Therapy
Cohort studyCardio-oncology & other
JACC CardioOncol
Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance
Cohort studyCardio-oncology & other
JACC CardioOncol
JACC CardioOncol
Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy
Secondary analysisCardio-oncology & other
JACC CardioOncol
JACC CardioOncol
Cardiovascular Considerations After Cancer Therapy
Guideline or statementCardio-oncology & other
JACC CardioOncol
Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients
Cohort studyCardio-oncology & other
JACC CardioOncol
Effects of Systemic Anticancer Treatment on Cardiorespiratory Fitness
Meta-analysisCardio-oncology & other
JACC CardioOncol
The Association of Malignancy With Stroke and Bleeding in Atrial Fibrillation
Cohort studyArrhythmias & EP
JACC CardioOncol
Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
Cohort studyCardio-oncology & other
JACC CardioOncol
Serum Proteins Predict Treatment-Related Cardiomyopathy Among Survivors of Childhood Cancer
Case-control studyCardio-oncology & other
JACC CardioOncol
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for Lymphoma
Cohort studyCardio-oncology & other
JACC CardioOncol
Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy
Cross-sectional studyPrevention & lipids
JACC CardioOncol
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors
Cohort studyPulmonary vascular & VTE
JACC CardioOncol
Cardiovascular Considerations During Cancer Therapy
Guideline or statementCardio-oncology & other
JACC CardioOncol
Predictors of Atrial Fibrillation After Thoracic Radiotherapy
Cohort studyArrhythmias & EP
JACC CardioOncol
Incident Myocardial Infarction, Heart Failure, and Oncologic Outcomes in Breast Cancer Survivors
Cohort studyCardio-oncology & other
JACC CardioOncol
Cardiovascular Disease With Hormone Therapy and Ovarian Suppression in Premenopausal Breast Cancer Survivors
Cohort studyCardio-oncology & other
JACC CardioOncol
Autonomic Dysfunction Among Adult Survivors of Childhood Cancer in the St. Jude Lifetime Cohort Study
Cross-sectional studyCardio-oncology & other
JACC CardioOncol
Atherosclerotic Cardiovascular Diseases Are Associated With Incident Metastatic and Nonmetastatic Cancer
Cohort studyCardio-oncology & other
JACC CardioOncol